Comparing two ways to stabilize the bicuspid aortic valve during repair
Official title: Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial
Run by University Hospital Augsburg · NCT06869954 · Data updated 2026-11-12
This trial will test whether an internal HAART 200 annuloplasty device or a double external ring annuloplasty gives better repair results for adults with asymmetric bicuspid aortic valves and severe aortic regurgitation who need valve surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital Augsburg Academic / other |
| Locations | 4 sites (Augsburg, Bavaria and 3 other locations) |
| Status | Recruiting |
| Started | May 21, 2025 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | October 7, 2025 |
| Trial ID | NCT06869954 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with a fused, asymmetric bicuspid aortic valve and severe aortic regurgitation who are scheduled for isolated aortic valve surgery (or with allowed concomitant procedures) and can give informed consent are ideal candidates.
✕Probably not a fit
Patients with moderate/severe stenosis, extensive cusp calcification that prevents repair, root aneurysm, or other anatomical features that make repair infeasible are unlikely to benefit from the randomized comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
CONTOUR is a multicenter, randomized trial in Germany enrolling 100 adults with fused, asymmetric bicuspid aortic valves and severe aortic regurgitation to compare two annuloplasty concepts. Eligible patients without a concomitant root aneurysm are randomized 1:1 to receive either an internal HAART 200 annuloplasty device or a double external ring annuloplasty at the time of aortic valve repair. The trial will collect surgical, echocardiographic, and clinical outcomes to compare annular stabilization, recurrence of regurgitation, and need for reoperation. Participating centers include University Hospital Augsburg, Universitätsklinikum Hamburg-Eppendorf, University Heart and Vascular Center Frankfurt, and Heart Center Leipzig.
Why it matters
Potential benefit: If successful, the better annuloplasty method could make bicuspid aortic valve repairs last longer and reduce the need for repeat operations.
How similar studies have gone: Device-specific and observational series have shown promise for both internal and external annuloplasty approaches, but randomized comparisons like this are novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Presence of fused BAV phenotype with an asymmetric configuration (commissural orientation \< 170 degree) \[14\] 2. Severe aortic regurgitation (vena contracta (vc) \> 6mm and/or pressure half-time (PHT) \< 200 ms and/or effective regurgitant orifice area (EROA) \> 30 mm2 and/or regurgitant volume (RV) \> 60 ml/beat and/or left ventricular end-systolic diameter (LVESD) \> 50mm (or indexed LVESD \> 20mm/m2 BSA) and/or regurgitation fraction (RF) in cardiothoracic MRI \> 40%) (at least one parameter is required) \[15\] 3. Isolated aortic valve surgery or concomitant procedure (including CABG and/or mitral/tricuspid valve surgery and/or ascending aortic surgery) 4. Willingness to participate and written informed consent 5. Age at surgery \> 18 years Exclusion Criteria: 1. Moderate/severe BAV stenosis (pmean \> 20mmHg) 2. Moderate/severe BAV cusp calcifications extending beyond the raphe region and/or necessitating patch implantation (deemed irreparable based on preoperative TOE (as by decision of the operating surgeon) 3. Concomitant aortic root aneurysm \> 45mm requiring simultaneous aortic root surgery \[16\] 4. Acute/subacute BAV endocarditis 5. Contraindication to MRI
Where it's running
-
University Hospital Augsburg
Augsburg, Bavaria, Germany Recruiting -
Medical Center Hamburg-Eppendorf
Hamburg, Germany Recruiting -
University Heart and Vascular Center Frankfurt
Frankfurt am Main, Hesse, Germany Not yet recruiting -
Heart Center Leipzig
Leipzig, Saxony, Germany Not yet recruiting
Study contacts
- Study coordinator: Evaldas Girdauskas, Prof.
- Email: evaldas.girdauskas@uk-augsburg.de
- Phone: +49 821 4002671
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aspirin by itself after TAVR for pure aortic regurgitation
In people with severe aortic regurgitation who have had TAVR and do not need long-term anticoagulation, this study tests whether aspirin alone for a year is safer and as effective as a short course of warfarin followed by aspirin.
-
AI tool to detect and measure aortic regurgitation
This project will test an AI-assisted echocardiography tool to detect and measure aortic regurgitation in adults and compare its results with standard manual measurements.
-
Finger photoacoustic arterial waveform monitoring for aortic valve disease and healthy adults
This project will test whether a finger-based photoacoustic device can capture arterial pulse waveforms and help identify aortic stenosis, aortic regurgitation, or normal heart function in adults.
-
Losartan after aortic valve replacement to help the heart recover
This trial will try if taking losartan after aortic valve replacement helps the heart shrink back to a healthier size and improve recovery in adults who had severe aortic regurgitation.
-
ARTEMIS: JenaValve Trilogy data collection for severe aortic regurgitation
This project will try the JenaValve Trilogy transcatheter heart valve in adults with severe native aortic regurgitation who are high or prohibitive risk for open-heart surgery.
-
Assessing how anesthesia and imaging affect aortic regurgitation evaluation
This study is testing how different types of heart imaging before and after anesthesia affect the way doctors measure aortic regurgitation in patients getting heart surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.